1-4 of 4
E Susan Amirian, PhD MS
Close
Sort by
Journal Articles

Treatment Patterns and Outcomes of 159 Ibrutinib-Treated MCL Patients in the United States: A Retrospective Electronic Medical Record Database and Chart Review Study

Jeff Sharman, MD, Shaum Kabadi, PhD MPH, Jamyia Clark, MPH, E Susan Amirian, PhD MS, David J. Andorsky, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4163.
https://doi.org/10.1182/blood-2018-99-118848
Published: 2018
Journal Articles

Carfilzomib Dosing Patterns and Time to Next Treatment Among Adult Patients with Multiple Myeloma Treated in the US Community Oncology Setting

Robert M Rifkin, MD, E Susan Amirian, PhD MS, Rohan Medhekar, PhD, Thomas Wilson, PhD DrPH, Marley Boyd, MS, Khalid Mezzi, MD MBA, Sumeet Panjabi, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3433.
https://doi.org/10.1182/blood.V130.Suppl_1.3433.3433
Published: 2017
Journal Articles

A Real-World Comparative Analysis of Carfilzomib and Other Systemic Multiple Myeloma Chemotherapies in the US Community Oncology Setting

Robert M Rifkin, MD, Rohan Medhekar, PhD, E Susan Amirian, PhD MS, Thomas Wilson, PhD DrPH, Marley Boyd, MS, Khalid Mezzi, MD MBA, Sumeet Panjabi, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3434.
https://doi.org/10.1182/blood.V130.Suppl_1.3434.3434
Published: 2017
Journal Articles

Clinical Profiles, Treatment Characteristics and Outcomes Among Newly Diagnosed Hodgkin Lymphoma Patients Presenting with Unfavorable and Advanced Disease within a US Community Oncology Setting

Christopher A. Yasenchak, MD, Joseph Feliciano, PharmD, Kathleen M. Aguilar, MPH, Jamyia Clark, MPH, E Susan Amirian, PhD MS, Akshara Richhariya, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5177.
https://doi.org/10.1182/blood.V130.Suppl_1.5177.5177
Published: 2017